查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1474874

ECMO 插管市場規模、佔有率、趨勢分析報告：按類型、按患者類型、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

Extracorporeal Membrane Oxygenation Cannula Market Size, Share & Trends Analysis Report By Type (Veno-arterial, Arterio-venous), By Patient Type (Adult, Pediatric), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

ECMO 插管市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球ECMO插管市場規模將達4,380萬美元，2024年至2030年複合年成長率為4.6%。

呼吸系統疾病和心臟病盛行率的增加是推動市場成長的主要因素。例如，2023年11月，中國國家衛生健康委員會指出，呼吸道疾病的增加歸因於COVID-19措施的放鬆以及流感、黴漿菌肺炎、呼吸道融合細胞病毒（RSV）和SARS-CoV。 （例如-2）的存在有關。全球醫療保健格局正受到老年人口擴張的極大影響，導致心肺疾病等與老齡化相關的疾病迅速增加。

世界衛生組織（WHO）預測，到2030年，全球六分之一的人口將超過60歲，這一年齡層的人口將從2020年的10億增加到14億。鬱血性心臟衰竭、慢性阻塞性肺病(COPD) 和肺纖維化等疾病通常會導致呼吸和心臟衰竭，需要先進的維生介入措施，例如 ECMO 治療。因此，這些疾病在全球範圍內的普遍存在凸顯了加強衛生基礎設施和服務以滿足老齡化人口不斷變化的需求的重要性。此外，當心肺復甦術 (CPR) 等傳統干預措施不成功時，ECMO 也可用於治療心臟衰竭或呼吸衰竭的情況。

ECMO 有多種用途，包括體外二氧化碳清除 (ECCO2R)、兒童和新生兒護理、作為恢復和移植的管道、促進院內轉運、管理心臟麻痹以及解決心臟衰竭和呼吸衰竭的醫療狀況。此外，透過 ECMO 進行的院內轉運正在重症加護環境中獲得認可。美國國立衛生美國(NIH) 2023 年 8 月發表的一篇論文認為，在呼吸衰竭的加護治療過程中，肥胖成年人可能會氧氣療法(ECMO)，這是一種先進的呼吸支持形式。因此，ECMO應用的擴大預計將有助於市場成長。

ECMO插管市場報告亮點

  • 靜脈-動脈型細分市場在2023 年佔據最大佔有率，約為45%，由於靜脈-動脈(VA) ECMO 系統和循環迴路的廣泛使用，預計2024 年至2030 年將以5.0% 的複合年成長率成長和呼吸功能預計成長最快。
  • 2023年，成人患者類型將佔據最大佔有率，約為64%，並且由於患有ARDS等呼吸系統疾病的患者數量眾多，預計2024年至2030年將經歷最快的成長。
  • 由於ECMO廣泛應用於呼吸窘迫症候群、呼吸衰竭、肺炎和肺動脈高壓等各種呼吸道疾病，呼吸應用領域在2023年佔據最大佔有率，約47%。
  • 由於擴大使用 ECPR 來治療對傳統心肺復甦無反應的心臟麻痹患者，體外心肺復甦術 (ECPR) 領域從 2024 年到 2030 年的複合年成長率將達到 5.25%。
  • 由於可一站式提供各種服務，醫院最終用途部分是治療和手術的首選，並且在 2023 年佔據主導地位，佔有率為 54.69%。
  • 預計 2024 年至 2030 年，門診手術中心細分市場將以最快的複合年成長率成長。
  • 2021 年 2 月，美敦力根據 FDA 指南暫時修改了其重症加護產品，以應對 COVID-19。 Bio-Medicus 成人插管和導引器、Bio-Medicus 插管套件和 Bio-Medicus 兒童插管等產品已針對 COVID-19 進行了修改，以支持 ECMO 治療中的擴展使用。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 ECMO插管市場變數及趨勢

  • 市場體系展望
  • 市場動態
    • 市場促進因素影響分析
    • 市場限制因素影響分析
  • 產業分析工具
    • 波特的分析
    • 宏觀經濟分析

第4章 ECMO 插管市場：類型分析

  • 2023年和2030年類型變化分析和市場佔有率
  • 按類型
  • 2018-2030 年市場規模與預測/趨勢分析

第5章 ECMO 插管市場：病患類型分析

  • 2023年和2030年患者類型變異分析和市場佔有率
  • 依患者類型
  • 2018-2030 年市場規模與預測/趨勢分析

第6章 ECMO 插管市場：應用分析

  • 2023年和2030年應用變化分析和市場佔有率
  • 按用途
  • 2018-2030 年市場規模與預測/趨勢分析

第7章 ECMO 插管市場：最終用途分析

  • 2023 年和 2030 年最終用途變化分析和市場佔有率
  • 按最終用途
  • 2018-2030 年市場規模與預測/趨勢分析

第8章 ECMO 插管市場：區域估計與趨勢分析

  • ECMO 插管市場：區域前景
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭分析

  • 公司分類
  • 參與企業概況
  • 財務績效
  • 企業定位分析
  • 產品基準化分析
  • 策略規劃
  • 公司簡介
    • Medtronic
    • LivaNova PLC
    • Edwards Lifesciences Corporation
    • Getinge
    • Andocor
    • Changzhou KangXin Medical Instruments Co., Ltd
    • Free Life Medical GmbH
    • Fresenius Medical Care AG
    • Abbott

第10章分析師的觀點

Product Code: GVR-4-68040-256-7

Extracorporeal Membrane Oxygenation Cannula Market Growth & Trends:

The global extracorporeal membrane oxygenation cannula market size is anticipated to reach USD 43.8 million by 2030, registering a CAGR of 4.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of respiratory & cardiac disorders is the major factor contributing to market growth. For instance, in November 2023, the National Health Commission in China noted a rise in respiratory illnesses, attributing it to the relaxation of COVID-19 measures and the presence of familiar pathogens like influenza, mycoplasma pneumonia, respiratory syncytial virus (RSV), and SARS-CoV-2. The global healthcare landscape is significantly influenced by the expanding elderly population, leading to a surge in age-related ailments, such as heart and lung diseases.

The World Health Organization (WHO) predicted that by 2030, one in every six people worldwide will be aged 60 years or older, with the population in this age group projected to increase from 1 billion in 2020 to 1.4 billion. Conditions, such as congestive heart failure, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, frequently culminate in respiratory or cardiac failure, often necessitating advanced life support interventions like ECMO therapy. As such, the prevalence of these conditions underscores the importance of enhancing healthcare infrastructure and services to cater to the evolving needs of aging populations globally. Moreover, ECMO is utilized in instances of cardiac or respiratory failure when conventional interventions like Cardiopulmonary Resuscitation (CPR) have not yielded success.

Its utilization spans a spectrum of medical scenarios, encompassing Extracorporeal CO2 Removal (ECCO2R), pediatric and neonatal care, acting as a conduit to recovery or transplantation, facilitating in-hospital transport, managing cardiac arrest, and addressing both cardiac and respiratory failure. Furthermore, there has been a growing acceptance of ECMO for in-hospital transport within critical care environments. As per an article published by the National Institute of Health (NIH) in August 2023, adults suffering from obesity may find extracorporeal membrane oxygenation (ECMO), an advanced form of respiratory support, beneficial during intensive care for respiratory failure. Hence, the growing applications of ECMO are expected to contribute to market growth.

Extracorporeal Membrane Oxygenation Cannula Market Report Highlights:

  • The veno-arterial type segment held the largest share of around 45% in 2023 and is expected to grow at the fastest CAGR of 5.0% from 2024 to 2030 owing to the wide use of Veno-Arterial (VA) ECMO systems & circuits for circulatory and respiratory functions
  • The adult patient type segment held the largest share of around 64% in 2023 and is anticipated to witness the fastest growth from 2024 to 2030 due to many patients suffering from respiratory conditions, such as ARDS
  • The respiratory application segment accounted for the largest share of around 47% in 2023 due to the extensive use of ECMO in various respiratory conditions, such as respiratory distress syndrome, respiratory failure, pneumonia, and pulmonary hypertension In addition, the high prevalence of these conditions will propel the segment growth further
  • The Extracorporeal Cardiopulmonary Resuscitation (ECPR) segment will witness the fastest CAGR of 5.25% from 2024 to 2030 due to the rising use of ECPR for treating patients with cardiac arrest who do not respond to conventional cardiopulmonary resuscitation
  • The hospitals end-use segment dominated with a 54.69% share in 2023 as they are preferred for treatments and surgeries due to the availability of various services under one roof
  • The ambulatory surgical centers segment is expected to grow at the fastest CAGR from 2024 to 2030
  • In February 2021, Medtronic temporarily modified its critical care products to address COVID-19 as per the guidelines of the FDA. Products such as Bio-Medicus Adult Cannula and Introducers, Bio-Medicus Cannula Kits, & Bio-Medicus Pediatric Cannula were modified to support longer-duration use in ECMO therapy to address COVID-19

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
  • 1.2 Market Definition
    • 1.2.1 Type
    • 1.2.2 Patient Type
    • 1.2.3 Application
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape

Chapter 3 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Variables and Trends

  • 3.1 Market Lineage Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Increasing prevalence of respiratory and cardiac disorders
      • 3.2.1.2 Rising geriatric population
      • 3.2.1.3 Rising applications in ECMO
    • 3.2.2 Market Restraint Impact Analysis
      • 3.2.2.1 Risks associated with ECMO
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Analysis
    • 3.3.2 Macroeconomic Analysis

Chapter 4 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Type Analysis

  • 4.1 Type Movement Analysis & Market Share, 2023 & 2030
  • 4.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by Type (USD Million)
  • 4.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 4.3.1 Veno-Arterial
      • 4.3.1.1 Veno-Arterial Market, 2018 - 2030 (USD Million)
    • 4.3.2 Veno-Venous
      • 4.3.2.1 Veno-Venous Market, 2018 - 2030 (USD Million)
    • 4.3.3 Arterio-Venous
      • 4.3.3.1 Arterio-venous market, 2018 - 2030 (USD Million)

Chapter 5 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Patient Type Analysis

  • 5.1 Patient Type Movement Analysis & Market Share, 2023 & 2030
  • 5.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by Patient Type (USD Million)
  • 5.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 5.3.1 Adult
      • 5.3.1.1 Adult Market, 2018 - 2030 (USD Million)
    • 5.3.2 Pediatric
      • 5.3.2.1 Pediatric market, 2018 - 2030 (USD Million)
    • 5.3.3 Neonates
      • 5.3.3.1 Neonates market, 2018 - 2030 (USD Million)

Chapter 6 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Application Analysis

  • 6.1 Application Movement Analysis & Market Share, 2023 & 2030
  • 6.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by Application (USD Million)
  • 6.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 6.3.1 Respiratory
      • 6.3.1.1 Respiratory Market, 2018 - 2030 (USD Million)
    • 6.3.2 Cardiac
      • 6.3.2.1 Cardiac market, 2018 - 2030 (USD Million)
    • 6.3.3 ECPR
      • 6.3.3.1 ECPR market, 2018 - 2030 (USD Million)

Chapter 7 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: End-use Analysis

  • 7.1 End-use Movement Analysis & Market Share, 2023 & 2030
  • 7.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by End-use (USD Million)
  • 7.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 7.3.1 Hospitals
      • 7.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
    • 7.3.2 Ambulatory Surgical Centers
      • 7.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
    • 7.3.3 Others
      • 7.3.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 8 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Regional Estimates & Trend Analysis

  • 8.1 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 Competitive Scenario
      • 8.2.2.3 Regulatory Scenario
      • 8.2.2.4 Reimbursement Scenario
      • 8.2.2.5 U.S. Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Competitive Scenario
      • 8.2.3.3 Regulatory Framework
      • 8.2.3.4 Reimbursement Scenario
      • 8.2.3.5 Canada Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Competitive Scenario
      • 8.3.2.3 Regulatory Framework
      • 8.3.2.4 Reimbursement Scenario
      • 8.3.2.5 Germany Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3 UK
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Competitive Scenario
      • 8.3.3.3 Regulatory Framework
      • 8.3.3.4 Reimbursement Scenario
      • 8.3.3.5 UK Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 Competitive Scenario
      • 8.3.4.3 Regulatory Framework
      • 8.3.4.4 Reimbursement Scenario
      • 8.3.4.5 France Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Competitive Scenario
      • 8.3.5.3 Regulatory Framework
      • 8.3.5.4 Reimbursement Scenario
      • 8.3.5.5 Italy Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Competitive Scenario
      • 8.3.6.3 Regulatory Framework
      • 8.3.6.4 Reimbursement Scenario
      • 8.3.6.5 Spain Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Competitive Scenario
      • 8.3.7.3 Regulatory Framework
      • 8.3.7.4 Reimbursement Scenario
      • 8.3.7.5 Denmark Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Competitive Scenario
      • 8.3.8.3 Regulatory Framework
      • 8.3.8.4 Reimbursement Scenario
      • 8.3.8.5 Sweden Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Competitive Scenario
      • 8.3.9.3 Regulatory Framework
      • 8.3.9.4 Reimbursement Scenario
      • 8.3.9.5 Norway Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Ecmo Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Competitive Scenario
      • 8.4.2.3 Regulatory Framework
      • 8.4.2.4 Reimbursement Scenario
      • 8.4.2.5 Japan Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 Competitive Scenario
      • 8.4.3.3 Regulatory Framework
      • 8.4.3.4 Reimbursement Scenario
      • 8.4.3.5 China Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 Competitive Scenario
      • 8.4.4.3 Regulatory Framework
      • 8.4.4.4 Reimbursement Scenario
      • 8.4.4.5 India Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Competitive Scenario
      • 8.4.5.3 Regulatory Framework
      • 8.4.5.4 Reimbursement Scenario
      • 8.4.5.5 Australia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.6 South Korea
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Competitive Scenario
      • 8.4.6.3 Regulatory Framework
      • 8.4.6.4 Reimbursement Scenario
      • 8.4.6.5 South Korea Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Competitive Scenario
      • 8.4.7.3 Regulatory Framework
      • 8.4.7.4 Reimbursement Scenario
      • 8.4.7.5 Thailand Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Competitive Scenario
      • 8.5.2.3 Regulatory Framework
      • 8.5.2.4 Reimbursement Scenario
      • 8.5.2.5 Brazil Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Competitive Scenario
      • 8.5.3.3 Regulatory Framework
      • 8.5.3.4 Reimbursement Scenario
      • 8.5.3.5 Mexico Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Competitive Scenario
      • 8.5.4.3 Regulatory Framework
      • 8.5.4.4 Reimbursement Scenario
      • 8.5.4.5 Argentina Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Middle East & Africa Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 Competitive Scenario
      • 8.6.2.3 Regulatory Framework
      • 8.6.2.4 Reimbursement Scenario
      • 8.6.2.5 South Africa Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Competitive Scenario
      • 8.6.3.3 Regulatory Framework
      • 8.6.3.4 Reimbursement Scenario
      • 8.6.3.5 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 Competitive Scenario
      • 8.6.4.3 Regulatory Framework
      • 8.6.4.4 Reimbursement Scenario
      • 8.6.4.5 UAE Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Competitive Scenario
      • 8.6.5.3 Regulatory Framework
      • 8.6.5.4 Reimbursement Scenario
      • 8.6.5.5 Kuwait Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9 Competitive Analysis

  • 9.1 Company Categorization
  • 9.2 Participants' Overview
  • 9.3 Financial Performance
  • 9.4 Company Positioning Analysis
  • 9.5 Product Benchmarking
  • 9.6 Strategy Mapping
    • 9.6.1 Mergers & Acquisitions
    • 9.6.2 Product Launch
    • 9.6.3 Product Approvals
    • 9.6.4 Others
  • 9.7 Company Profiles
    • 9.7.1. Medtronic
      • 9.7.1.1. Company Overview
      • 9.7.1.2. Financial Performance
      • 9.7.1.3. Form Portfolios
      • 9.7.1.4. Strategic Initiatives
    • 9.7.2. LivaNova PLC
      • 9.7.2.1. Company Overview
      • 9.7.2.2. Financial Performance
      • 9.7.2.3. Form Portfolios
      • 9.7.2.4. Strategic Initiatives
    • 9.7.3. Edwards Lifesciences Corporation
      • 9.7.3.1. Company Overview
      • 9.7.3.2. Financial Performance
      • 9.7.3.3. Form Portfolios
      • 9.7.3.4. Strategic Initiatives
    • 9.7.4. Getinge
      • 9.7.4.1. Company Overview
      • 9.7.4.2. Financial Performance
      • 9.7.4.3. Form Portfolios
      • 9.7.4.4. Strategic Initiatives
    • 9.7.5. Andocor
      • 9.7.5.1. Company Overview
      • 9.7.5.2. Financial Performance
      • 9.7.5.3. Form Portfolios
      • 9.7.5.4. Strategic Initiatives
    • 9.7.6. Changzhou KangXin Medical Instruments Co., Ltd
      • 9.7.6.1. Company Overview
      • 9.7.6.2. Financial Performance
      • 9.7.6.3. Form Portfolios
      • 9.7.6.4. Strategic Initiatives
    • 9.7.7. Free Life Medical GmbH
      • 9.7.7.1. Company Overview
      • 9.7.7.2. Financial Performance
      • 9.7.7.3. Form Portfolios
      • 9.7.7.4. Strategic Initiatives
    • 9.7.8. Fresenius Medical Care AG
      • 9.7.8.1. Company Overview
      • 9.7.8.2. Financial Performance
      • 9.7.8.3. Form Portfolios
      • 9.7.8.4. Strategic Initiatives
    • 9.7.9. Abbott
      • 9.7.9.1. Company Overview
      • 9.7.9.2. Financial Performance
      • 9.7.9.3. Form Portfolios
      • 9.7.9.4. Strategic Initiatives

Chapter 10 Analyst Perspective

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 5 North America extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 9 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 13 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 18 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 22 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 26 UK extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 27 UK extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 France extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 29 France extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 30 France extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 31 France extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 34 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 38 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 41 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 42 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 43 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 45 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 46 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 47 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 49 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 50 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 51 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 China extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 58 China extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 59 China extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 60 China extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 62 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 63 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 64 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 India extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 66 India extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 67 India extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 68 India extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 70 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 71 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 72 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 74 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 75 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 76 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 78 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 79 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 80 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
  • Table 82 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 83 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 84 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 85 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 87 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 88 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 91 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 92 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 93 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 95 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 96 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 100 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 101 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 102 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 105 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 112 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 113 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Extracorporeal Membrane Oxygenation (ECMO) cannula market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot, USD Million
  • Fig. 9 Segment snapshot (Type and Patient Type )
  • Fig. 10 Segment snapshot (Application and End Use)
  • Fig. 11 Competitive landscape
  • Fig. 12 Cannula and ECMO cannula market value, 2023 (USD million)
  • Fig. 13 Extracorporeal Membrane Oxygenation (ECMO) cannula market dynamics
  • Fig. 14 Extracorporeal Membrane Oxygenation (ECMO) cannula market: PORTER's analysis
  • Fig. 15 Extracorporeal Membrane Oxygenation (ECMO) cannula market: PESTEL analysis
  • Fig. 16 Extracorporeal Membrane Oxygenation (ECMO) cannula market by type: Key takeaways
  • Fig. 17 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by type: Market share, 2023 & 2030
  • Fig. 18 Veno-arterial market, 2018 - 2030 (USD Million)
  • Fig. 19 Veno-venous market, 2018 - 2030 (USD Million)
  • Fig. 20 Arterio-venous market, 2018 - 2030 (USD Million)
  • Fig. 21 Extracorporeal Membrane Oxygenation (ECMO) cannula market by patient type: Key takeaways
  • Fig. 22 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by patient type: Market share, 2023 & 2030
  • Fig. 23 Adult market, 2018 - 2030 (USD Million)
  • Fig. 24 Pediatric market, 2018 - 2030 (USD Million)
  • Fig. 25 Neonates market, 2018 - 2030 (USD Million)
  • Fig. 26 Extracorporeal Membrane Oxygenation (ECMO) cannula market by application: Key takeaways
  • Fig. 27 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by application: Market share, 2023 & 2030
  • Fig. 28 Respiratory market, 2018 - 2030 (USD Million)
  • Fig. 29 Cardiac market, 2018 - 2030 (USD Million)
  • Fig. 30 ECPR market, 2018 - 2030 (USD Million)
  • Fig. 31 Extracorporeal Membrane Oxygenation (ECMO) cannula market by end use: Key takeaways
  • Fig. 32 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by end use: Market share, 2023 & 2030
  • Fig. 33 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 34 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 35 Others market, 2018 - 2030 (USD Million)
  • Fig. 36 Extracorporeal Membrane Oxygenation (ECMO) cannula market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 North America Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Reimbursement procurement process
  • Fig. 42 U.S. Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Number of key elements by type of center, 2021
  • Fig. 45 Canada Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Extracorporeal Membrane Oxygenation (ECMO) Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 France Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Spain Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Denmark Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Sweden Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Norway Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Reimbursement procurement process
  • Fig. 66 Japan Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 China Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 India Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Korea Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Thailand Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Brazil Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Mexico Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Argentina Extracorporeal Membrane Oxygenation (ECMO) Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Africa Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 UAE Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Kuwait Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key company categorization
  • Fig. 94 Company positioning analysis
  • Fig. 95 Strategy mapping